Many cancer-associated mutational signatures remain unexplained. Team CAUSE aims to connect DNA damage, mutational patterns, ...
MAIA recently announced that it has completed international enrollment in Part C of the Phase 2 THIO-101 expansion trial. Treatment with ateganosine followed by cemiplimab has shown an acceptable ...
(DCR) observed with combination therapy Initial Part C efficacy observations align with previously reported THIO-101 clinical activity despite a more heavily pre-treated ...
There is one thing that is the leading cancer risk factor, responsible for 60 percent of all diagnoses - it outranks smoking, ...
Dr. Priya Hays discusses the mechanisms of treatment resistance in cancer, highlighting their significance for developing ...
DNA on a towel concealing the suspected murder weapon and a screwdriver found at the sniper's perch matched both Tyler ...
The security vendor’s global CTO argues that AI’s non-deterministic nature requires a new approach to cybersecurity that ...
Police found Dean Foord hiding in a fridge before he was jailed for actual bodily harm and criminal damage.